MAM
INO icon

Meeder Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

Meeder Asset Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed -$3K – 2409
2021
Q4 		$3K Hold
50
– – ﹤0.01% 937
2021
Q3 		$4K Hold
50
– – ﹤0.01% 2001
2021
Q2 		$6K Hold
50
– – ﹤0.01% 1874
2021
Q1 		$6K Sell
50
-140
-74% -$18.4K ﹤0.01% 1791
2020
Q4 		$20K Sell
190
-219
-54% -$29.2K ﹤0.01% 788
2020
Q3 		$57K Sell
409
-11
-3% -$2.29K ﹤0.01% 928
2020
Q2 		$137K Buy
420
+354
+536% +$56.8K 0.01% 692
2020
Q1 		$5K Buy
+66
New +$4.07K ﹤0.01% 1783
2019
Q2 		– Sell
-411
Closed -$18K – 2083
2019
Q1 		$18K Sell
411
-816
-67% -$41.1K ﹤0.01% 1103
2018
Q4 		$59K Buy
1,227
+1,030
+523% +$62.6K 0.01% 770
2018
Q3 		$13K Buy
197
+158
+405% +$8.8K ﹤0.01% 1115
2018
Q2 		$1.84K Buy
39
+25
+179% +$1.38K ﹤0.01% 1427
2018
Q1 		$1K Sell
14
-31
-69% -$1.68K ﹤0.01% 1454
2017
Q4 		$2K Sell
45
-13
-22% -$806 ﹤0.01% 1491
2017
Q3 		$4K Sell
58
-49
-46% -$3.65K ﹤0.01% 1321
2017
Q2 		$10K Hold
107
– – ﹤0.01% 990
2017
Q1 		$9K Buy
107
+41
+62% +$3.27K ﹤0.01% 875
2016
Q4 		$5K Buy
+66
New +$5.97K ﹤0.01% 856

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Meeder Asset Management's INO Position: Q1 2022 in Review

Meeder Asset Management sold out of Inovio Pharmaceuticals (INO) in Q1 2022, closing a stake of 50 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in INO in Q4 2016 and held it in 18 quarters. The position peaked at $137K in Q2 2020. 198 funds tracked by Wall St. Rank hold INO as of Q1 2022.

  • Meeder Asset Management reported no remaining Inovio Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Meeder Asset Management sold 50 Inovio Pharmaceuticals shares in Q1 2022, an estimated $3K.
  • Meeder Asset Management first reported a position in Inovio Pharmaceuticals in Q4 2016 and held it in 18 quarters.
  • Meeder Asset Management's Inovio Pharmaceuticals position peaked at $137K in Q2 2020.
  • 198 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2022.

Based on Meeder Asset Management's 13F filing for Q1 2022, filed 10 May 2022.